EW | Edwards Lifesciences
93.02 -0.62 (-0.66%)
EW Price Profile
$91.97
$93.02
91.34 - 94.05
91.34 - 131.73
67.69B
602.07K
93.64
118.97
624.33M
619.13M
2.24M
1.09
3.34
6.08M
0.98%
2.31
29.05%
2.33
0.15
1.72B
3.31B
1.79B
684.1M
- MRQ = Most Recent Quarter.
- TTM = Trailing Twelve Months.
Edwards Lifesciences (EW) company profile
Edwards Lifesciences (NYSE: EW) is an American company that designs, develops, and markets products and services to treat heart-related diseases. It offers transcatheter heart and surgical heart valves, heart valve repair, cardiac cannula, hemodynamic monitoring, pressure monitoring, vascular surgery, and investigational devices. Additionally, it provides surgical heart valve therapy products, including pericardial valves for aortic and mitral surgical valve replacement, aortic heart valves; annuloplasty rings; cardiac cannula devices; a beating heart mitral valve repair system for the treatment of degenerative mitral regurgitation.
